1994
Epidemiology of Hepatitis B Virus Infections among Injecting Drug Users: Seroprevalence, Risk Factors, and Viral Interactions
Levine O, Vlahov D, Nelson K. Epidemiology of Hepatitis B Virus Infections among Injecting Drug Users: Seroprevalence, Risk Factors, and Viral Interactions. Epidemiologic Reviews 1994, 16: 418-436. PMID: 7713187, DOI: 10.1093/oxfordjournals.epirev.a036161.Peer-Reviewed Original Research
1991
Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.
Viscidi R, Hill P, Li S, Cerny E, Vlahov D, Farzadegan H, Halsey N, Kelen G, Quinn T. Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1991, 4: 1190-8. PMID: 1941526.Peer-Reviewed Original ResearchConceptsEnzyme immunoassayHTLV-IIAntibody reactivityPeptide enzyme immunoassayHTLV-II infectionEpidemiology of HTLVDifferentiation of HTLVMicrotiter plate enzyme immunoassaysPattern of reactivitySeronegative controlsEmergency departmentEnv peptidesPositive seraViral infectionNeurological diseasesHTLVSynthetic peptidesInfectionDrug abuseMajor envelope proteinEnvEnvelope proteinPatientsSerumAntibodies
1988
Transmission of HIV-1 within a statewide prison system
Brewer T, Vlahov D, Taylor E, Hall D, Munoz A, Polk B. Transmission of HIV-1 within a statewide prison system. AIDS 1988, 2: 363-368. PMID: 3146264, DOI: 10.1097/00002030-198810000-00005.Peer-Reviewed Original Research